Related Experiment Videos
Problems in pathologic staging of lung cancer
1Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA. marchevsky@cshs.org
Archives of Pathology & Laboratory Medicine
|March 8, 2006
Summary
Accurate pathologic staging is crucial for lung cancer treatment decisions. This review highlights practical challenges in assessing tumor stage, lymph nodes, and other factors for optimal patient care.
Area of Science:
- Pathology
- Oncology
- Thoracic Surgery
Background:
- Tumor stage is the primary prognostic factor in lung cancer, guiding treatment decisions for surgical, radiation, and chemotherapy interventions.
- Lung cancer remains the leading cause of cancer-related mortality in the United States.
Purpose of the Study:
- To review practical challenges encountered during the pathologic staging of resected lung neoplasms.
- To discuss difficulties in evaluating prognostic and predictive factors outlined in the College of American Pathologists' checklist.
Main Methods:
- Review of potential practical difficulties in pathologic staging of lung cancer.
- Examination of criteria for distinguishing tumor size (pT1-pT3) and invasion.
- Analysis of differential diagnosis between primary lung neoplasms and intrapulmonary metastases.
- Evaluation of updated American Joint Committee on Cancer lymph node classification.
Main Results:
- Practical issues arise in differentiating tumor size and invasion (pT1-pT3).
- Distinguishing multiple primary tumors (pT1m) from intrapulmonary metastases (pT4/pM1) presents diagnostic challenges.
- Classification of lymph nodes, including isolated tumor cells and micrometastases, requires careful assessment.
Conclusions:
- Practical challenges exist in assessing resection margin status and lymphovascular invasion.
- The review addresses the impact of neoadjuvant therapy on the pathologic evaluation of resected lung neoplasms.